Gene · 5268
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Anti-tumor activity of all-trans retinoic acid in gastric-cancer: gene-networks and molecular mechanisms. | J Exp Clin Cancer Res | 2023 | 37951921 | PubTator, text mining | PubMed |
| Functional Proteomics Characterization of the Role of SPRYD7 in Colorectal Cancer Progression and Metastasis. | Cells | 2023 | 37947626 | PubTator, text mining | PubMed |
| Construction and validation of a novel angiogenesis pattern to predict prognosis and immunotherapy efficacy in colorectal cancer. | Aging (Albany NY) | 2023 | 37938164 | PubTator, text mining | PubMed |
| Aging and oral squamous cell carcinoma development: the role of cellular senescence. | Front Oral Health | 2023 | 37904749 | PubTator, text mining | PubMed |
| The role of CD14 and CSF1R in osteoarthritis and gastritis. | Medicine (Baltimore) | 2023 | 37904379 | PubTator, text mining | PubMed |
| Emerging roles of interactions between ncRNAs and other epigenetic modifications in breast cancer. | Front Oncol | 2023 | 37901333 | PubTator, text mining | PubMed |
| Filter and Wrapper Stacking Ensemble (FWSE): a robust approach for reliable biomarker discovery in high-dimensional omics data. | Brief Bioinform | 2023 | 37889118 | PubTator, text mining | PubMed |
| The anti-tumor potential of sinomenine: a narrative review. | Transl Cancer Res | 2023 | 37859743 | PubTator, text mining | PubMed |
| Similarities and differences in gene expression profiles of BRCA1 methylated and mutated epithelial ovarian cancers. | Front Oncol | 2023 | 37854675 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing in pancreatic cancer identifies disulfidptosis-associated molecular subtypes and prognostic signature. | Sci Rep | 2023 | 37845218 | PubTator, text mining | PubMed |
| Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed? | Nat Prod Bioprospect | 2023 | 37843642 | PubTator, text mining | PubMed |
Colloid Carcinoma Arising in an Intestinal-Type Intraductal Papillary Mucinous Neoplasm with High-Grade Dysplasia Appearing as Signet-Ring Cells of the Pancreas by Serial Pancreatic Juice Aspiration Cytology: A Case Report. | Diagnostics (Basel) | 2023 | 37835866 | PubTator, text mining | PubMed |
| Deciphering the Mysterious Relationship between the Cross-Pathogenetic Mechanisms of Neurodegenerative and Oncological Diseases. | Int J Mol Sci | 2023 | 37834214 | PubTator, text mining | PubMed |
| Comparative computational analysis to distinguish mesenchymal stem cells from fibroblasts. | Front Immunol | 2023 | 37822926 | PubTator, text mining | PubMed |
| Differential expression of mRNA 3'-end isoforms in cervical and ovarian cancers. | Heliyon | 2023 | 37810050 | PubTator, text mining | PubMed |
| Diagnosing and monitoring pancreatic cancer through cell-free DNA methylation: progress and prospects. | Biomark Res | 2023 | 37798621 | PubTator, text mining | PubMed |
| Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma. | Front Cell Dev Biol | 2023 | 37779898 | PubTator, text mining | PubMed |
| ΔNp63 silencing, DNA methylation shifts, and epithelial-mesenchymal transition resulted from TAp63 genome editing in squamous cell carcinoma. | Neoplasia | 2023 | 37778252 | PubTator, text mining | PubMed |
| Pancreatic Cancer and Detection Methods. | Biomedicines | 2023 | 37760999 | PubTator, text mining | PubMed |
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial). | BMC Cancer | 2023 | 37710198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5268/papers?page=6